12.01.2013 Views

NCI National Clinical Trials Network (NCTN) Program Guidelines

NCI National Clinical Trials Network (NCTN) Program Guidelines

NCI National Clinical Trials Network (NCTN) Program Guidelines

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PART 2: Submission of New/Competing Application Section II – Budget & Research Plan<br />

<strong>Network</strong> Group SDMCs<br />

2.1 Sub-section A. Statistics and Data Management Center Overview (up to 12 pages)<br />

This sub-section should provide a general overview of the Statistics and Data Management<br />

Center (SDMC) and describe the general features and operations of the SDMC. The<br />

applicant should provide a diagram illustrating the organizational structure of the SDMC in<br />

this sub-section, particularly the relationship between the Statistical Analysis <strong>Program</strong> and<br />

the Data Management <strong>Program</strong> and describe how the SDMC would interact with the other<br />

key components of the <strong>NCTN</strong> <strong>Program</strong>.<br />

The applicant's key standard operating procedures for the conduct of clinical trials related to<br />

the following should be provided in the Resource section of the application:<br />

� Procedures for Statistical Analysis (e.g., guidelines for interim monitoring, general<br />

procedures for sample size estimation, accrual rate estimation, and choice of<br />

testing and estimation procedures)<br />

� Data Management and Monitoring Policies & Procedures for <strong>Clinical</strong> <strong>Trials</strong><br />

� Procedures to Ensure Security and Confidentiality of Patient Data<br />

� Conflict of Interest Policy<br />

� Onsite Auditing Policy and Procedures<br />

� Model Statistical Analysis Template for <strong>Clinical</strong> <strong>Trials</strong><br />

� Sample of Trial Reports (i.e., 3 trials) from the SDMC Report of Studies<br />

2.2 Sub-section B. Statistical Analysis <strong>Program</strong> & Collaborative Research and Collective<br />

Management (up to 30 pages)<br />

Statistical Analysis <strong>Program</strong>: This functional component should consist of a well-defined<br />

organization, approaches, policies, and procedures for statistical analysis of clinical trials in<br />

specific disease areas and patient populations. The applicant should describe the<br />

organizational structure, governance, and standard operating procedures in order to<br />

demonstrate the applicant's capability to design, monitor, and analyze clinical trials in a<br />

timely manner. The expertise and experience as well as the scope and authority of the<br />

applicant's statistical leadership team, including how the team directs the Data Management<br />

<strong>Program</strong> and how the team interacts with the Director of Operations position for the<br />

associated <strong>Network</strong> Group Operations Center should be described, including succession<br />

planning for key leadership positions in the statistical program.<br />

For applications designating multiple PD(s)/PIs(s), a leadership plan related to the multiple<br />

PD/PI designation must be included in the appropriate section of the application (i.e.,<br />

Multiple <strong>Program</strong> Director(s)/Principal Investigator(s) (PD(s)/PIs(s), Leadership Plan section<br />

of the PHS 398). A rationale for choosing a multiple PD/PI approach should be described. The<br />

governance and organizational structure of the leadership team for the SDMC should be<br />

described including communication plans, process for making decisions and procedures for<br />

resolving conflicts. The roles and administrative, technical, and statistical responsibilities for<br />

the SDMC should be delineated for the PD(s)/PIs(s), including responsibilities for protection<br />

of information on human subjects in clinical studies. If budget allocation is planned, the<br />

distribution of resources to specific components of the SDMC and/or the individual<br />

PD(s)/PIs(s) should be delineated in the Leadership Plan. In the event of an award, the<br />

requested allocations may be reflected in a footnote of the Notice of Award.<br />

The applicant should describe the general approach to statistical trial design and analysis<br />

plans for multi-institutional clinical trials, including guidelines for interim monitoring and<br />

general procedures for sample size estimation and choice of testing and estimation<br />

procedures. Examples of robust statistical trial designs and statistical support should be<br />

Page 118 of 241

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!